These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 14621849

  • 1. Long-term immunosuppression after liver transplantation: are steroids necessary?
    Padbury RT, Gunson BK, Dousset B, Hubscher SG, Mayer AD, Buckels JA, Neuberger JM, Elias E, McMaster P.
    Transpl Int; 1992; 5 Suppl 1():S470-2. PubMed ID: 14621849
    [Abstract] [Full Text] [Related]

  • 2. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?
    Dmitrewski J, Ayres S, Gunson BK, Buist LJ, Buckels JA, McMaster P, Mayer AD.
    Transpl Int; 1994 Dec 20; 7 Suppl 1():S85-7. PubMed ID: 11271342
    [Abstract] [Full Text] [Related]

  • 7. Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantation.
    Faulhaber M, Mäding I, Malehsa D, Raggi MC, Haverich A, Bara CL.
    Int Immunopharmacol; 2013 Apr 20; 15(4):712-7. PubMed ID: 23454241
    [Abstract] [Full Text] [Related]

  • 8. Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients.
    Gómez R, Moreno E, Colina F, Loinaz C, Gonzalez-Pinto I, Lumbreras C, Perez-Cerdá F, Castellón C, García I.
    J Hepatol; 1998 Jan 20; 28(1):150-6. PubMed ID: 9537852
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Steroid withdrawal in renal transplant recipients.
    Ponticelli C, Tarantino A, Montagnino G.
    Transplant Proc; 2001 Jan 20; 33(1-2):987-8. PubMed ID: 11267158
    [No Abstract] [Full Text] [Related]

  • 12. Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy.
    De Carlis L, Belli LS, Colella G, Rondinara GF, Slim AO, Alberti A, Aseni P, Sansalone CV, Pirotta V, Di Benedetto F, Forti D.
    Transplant Proc; 1999 Jan 20; 31(1-2):391-3. PubMed ID: 10083156
    [No Abstract] [Full Text] [Related]

  • 13. A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation.
    Sandrini S, Maiorca R, Scolari F, Cancarini G, Setti G, Gaggia P, Cristinelli L, Zubani R, Bonardelli S, Maffeis R, Portolani N, Nodari F, Giulini SM.
    Transplantation; 2000 May 15; 69(9):1861-7. PubMed ID: 10830223
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
    Meadows HB, Taber DJ, Pilch NA, Tischer SM, Baliga PK, Chavin KD.
    Transplant Proc; 2012 Jun 15; 44(5):1323-8. PubMed ID: 22664009
    [Abstract] [Full Text] [Related]

  • 16. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM, Glanemann M, Guckelberger O, Klupp J, Neumann U, Machens C, Lohmann R, Knoop M, Lobeck H, Schlag H, Keck H, Settmacher U, Bechstein WO, Neuhaus PJ.
    Clin Transplant; 1998 Aug 15; 12(4):303-12. PubMed ID: 9686324
    [Abstract] [Full Text] [Related]

  • 17. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y, Kikuchi H, Fujimori K, Doi H, Orii T, Ohkohchi N, Satomi S.
    Transplant Proc; 2000 Nov 15; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
    Langrehr JM, Lohmann R, Raakow R, Jonas S, Klupp J, Bechstein WO, Neuhaus R, Neuhaus P.
    Transplant Proc; 2001 May 15; 33(3):2290-1. PubMed ID: 11377531
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.